ProPhase Labs Shares Outstanding 2006-2018 | PRPH

ProPhase Labs shares outstanding from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
ProPhase Labs Annual Shares Outstanding
(Millions of Shares)
2018 11
2017 16
2016 17
2015 16
2014 17
2013 16
2012 15
2011 15
2010 14
2009 13
2008 13
2007 13
2006 12
2005 13
ProPhase Labs Quarterly Shares Outstanding
(Millions of Shares)
Q4 2018 11
Q3 2018 12
Q2 2018 11
Q1 2018 11
Q4 2017 16
Q3 2017 16
Q2 2017 17
Q1 2017 18
Q4 2016 17
Q3 2016 18
Q2 2016 17
Q1 2016 17
Q4 2015 16
Q3 2015 17
Q2 2015 16
Q1 2015 16
Q4 2014 17
Q3 2014 18
Q2 2014 17
Q1 2014 16
Q4 2013 16
Q3 2013 16
Q2 2013 16
Q1 2013 16
Q4 2012 15
Q3 2012 15
Q2 2012 15
Q1 2012 15
Q4 2011 15
Q3 2011 15
Q2 2011 15
Q1 2011 15
Q4 2010 14
Q3 2010 15
Q2 2010 15
Q1 2010 13
Q4 2009 13
Q3 2009 13
Q2 2009 13
Q1 2009 13
Q4 2008 13
Q3 2008 13
Q2 2008 13
Q1 2008 13
Q4 2007 13
Q3 2007 13
Q2 2007 13
Q1 2007 13
Q4 2006 13
Q3 2006 13
Q2 2006 12
Q1 2006 12
Q4 2005 13
Q3 2005 13
Q2 2005 12
Q1 2005 12
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.035B $0.013B
ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals that offer pioneering new options to improve patient treatment results. Its consumer health products, marketed through ProPhase Labs and certain subsidiaries, include the original COLD-EEZE?, a zinc gluconate glycine product. COLD-EEZE? family of lozenges and sugar free tablets reduce the severity and duration of the common cold. Its customers include wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs is also engaged in the research and development of potential natural base health products along with supplements and cosmeceuticals for human and veterinary use. The Company is headquartered in Doylestown, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $47.457B 31.54
Takeda Pharmaceutical (TAK) Japan $28.357B 10.49
Grifols (GRFS) Spain $12.830B 15.68
Ionis Pharmaceuticals (IONS) United States $10.102B 32.30
Sage Therapeutics (SAGE) United States $7.758B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.328B 10.49
Neurocrine Biosciences (NBIX) United States $7.158B 461.35
Catalent (CTLT) United States $6.403B 26.81
Nektar Therapeutics (NKTR) United States $5.516B 8.80
Tilray (TLRY) United States $4.740B 0.00
United Therapeutics (UTHR) United States $4.387B 7.46
Taro Pharmaceutical Industries (TARO) Israel $4.097B 13.19
FibroGen (FGEN) United States $4.039B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.793B 0.00
Portola Pharmaceuticals (PTLA) United States $2.252B 0.00
PTC Therapeutics (PTCT) United States $2.099B 0.00
USANA Health Sciences (USNA) United States $1.921B 16.12
Heron Therapeutics (HRTX) United States $1.837B 0.00
Aerie Pharmaceuticals (AERI) United States $1.799B 0.00
Xencor (XNCR) United States $1.765B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.738B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.712B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.668B 20.77
Madrigal Pharmaceuticals (MDGL) United States $1.627B 0.00
Endo (ENDP) Ireland $1.598B 2.46
Zogenix (ZGNX) United States $1.534B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.518B 131.46
Corcept Therapeutics (CORT) United States $1.372B 19.93
Tricida (TCDA) United States $1.330B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.279B 0.00
Esperion Therapeutics (ESPR) United States $1.098B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.066B 0.00
TherapeuticsMD (TXMD) United States $1.020B 0.00
Radius Health (RDUS) United States $0.980B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.873B 0.00
Akebia Therapeutics (AKBA) United States $0.786B 0.00
CannTrust Holdings (CTST) Canada $0.751B 0.00
ArQule (ARQL) United States $0.713B 0.00
ChemoCentryx (CCXI) United States $0.700B 0.00
Dermira (DERM) United States $0.619B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.577B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.573B 0.00
Odonate Therapeutics (ODT) United States $0.573B 0.00
Forty Seven (FTSV) United States $0.559B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.546B 0.00
GlycoMimetics (GLYC) United States $0.523B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.460B 23.76
Corbus Pharmaceuticals Holdings (CRBP) United States $0.454B 0.00
Translate Bio (TBIO) United States $0.452B 0.00
Collegium Pharmaceutical (COLL) United States $0.451B 0.00
KalVista Pharmaceuticals (KALV) United States $0.440B 0.00
TCR2 THERAPTCS (TCRR) United States $0.439B 0.00
Siga Technologies (SIGA) United States $0.430B 0.00
OptiNose (OPTN) United States $0.408B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.396B 0.00
Flexion Therapeutics (FLXN) United States $0.388B 0.00
Aptorum Group (APM) China $0.388B 0.00
ImmunoGen (IMGN) United States $0.368B 0.00
Mast Therapeutics (SVRA) United States $0.334B 0.00
Harpoon Therapy (HARP) United States $0.317B 0.00
CASI Pharmaceuticals (CASI) United States $0.316B 0.00
Karyopharm Therapeutics (KPTI) United States $0.282B 0.00
Lannett Co Inc (LCI) United States $0.281B 2.61
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.276B 10.21
Minerva Neurosciences (NERV) United States $0.274B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.274B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.266B 0.00
Xeris Pharmaceuticals (XERS) United States $0.259B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.251B 0.00
Calithera Biosciences (CALA) United States $0.241B 0.00
Dova Pharmaceuticals (DOVA) United States $0.233B 0.00
Molecular Templates (MTEM) United States $0.231B 0.00
Aclaris Therapeutics (ACRS) United States $0.228B 0.00
Concert Pharmaceuticals (CNCE) United States $0.222B 0.00
Ardelyx (ARDX) United States $0.212B 0.00
Affimed (AFMD) Germany $0.209B 0.00
MEI Pharma (MEIP) United States $0.208B 0.00
Aldeyra Therapeutics (ALDX) United States $0.204B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.201B 0.00
Opexa Therapeutics (ACER) United States $0.200B 0.00
Galectin Therapeutics (GALT) United States $0.196B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.194B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.186B 0.00
Recro Pharma (REPH) United States $0.184B 0.00
Jounce Therapeutics (JNCE) United States $0.184B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.182B 189.00
ElectroCore (ECOR) United States $0.182B 0.00
Neon Therapeutics (NTGN) United States $0.177B 0.00
Majesco Entertainment (PTE) United States $0.174B 0.00
Redhill Biopharma (RDHL) Israel $0.172B 0.00
Aratana Therapeutics (PETX) United States $0.171B 0.00
IMV INC (IMV) Canada $0.170B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.168B 0.00
Tyme Technologies (TYME) United States $0.158B 0.00
Aquestive Therapeutics (AQST) United States $0.157B 0.00
Ocular Therapeutix (OCUL) United States $0.156B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.136B 0.00
MediWound (MDWD) Israel $0.132B 0.00
China SXT Pharmaceuticals (SXTC) China $0.119B 0.00
Iterum Therapeutics (ITRM) Ireland $0.114B 0.00
ProNAi Therapeutics (SRRA) Canada $0.109B 0.00
Cardiome Pharma (CORV) Canada $0.106B 0.00
Nivalis Therapeutics (ALPN) United States $0.105B 0.00
Natural Alternatives (NAII) United States $0.098B 9.62
Neos Therapeutics (NEOS) United States $0.097B 0.00
Zafgen (ZFGN) United States $0.097B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.094B 0.00
Adherex Technologies (FENC) United States $0.094B 0.00
DURECT (DRRX) United States $0.093B 0.00
Champions Oncology (CSBR) United States $0.092B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.091B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.090B 0.00
Infinity Pharmaceuticals (INFI) United States $0.089B 0.00
Bio Blast Pharma (ENLV) Israel $0.083B 0.00
SCYNEXIS (SCYX) United States $0.083B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Genocea Biosciences (GNCA) United States $0.078B 0.00
Avenue Therapeutics (ATXI) United States $0.075B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.072B 0.00
Capnia (SLNO) United States $0.064B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.057B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
Forward Pharma (FWP) Denmark $0.056B 0.00
Melinta Therapeutics (MLNT) United States $0.049B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 0.00
Bio-Path Holdings (BPTH) United States $0.048B 0.00
Lipocine (LPCN) United States $0.044B 0.00
KemPharm (KMPH) United States $0.043B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.043B 0.00
ContraFect (CFRX) United States $0.042B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.040B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Heat Biologics (HTBX) United States $0.038B 0.00
HANCOCK JAFFE (HJLI) United States $0.034B 0.00
Shineco (TYHT) China $0.029B 4.88
Summit Therapeutics (SMMT) United Kingdom $0.026B 3.47
PharmAthene (ALT) United States $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.024B 0.00
Achieve Life Sciences (ACHV) United States $0.024B 0.00
Biomerica (BMRA) United States $0.024B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
NOVAN INC (NOVN) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 4.07
Regulus Therapeutics (RGLS) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
Achaogen (AKAO) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00